http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103239665-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ea1be3fbc73275d799ca5a4b76442593 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-9062 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-583 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2013-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b13969b03f74f047d2b8a33e8ed448d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08029e2fa146b3947980ff302197a83a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25a950a8aacd0a863261d1b150ed961c |
| publicationDate | 2014-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103239665-B |
| titleOfInvention | Traditional Chinese medicine composition for treating sepsis |
| abstract | The invention provides a traditional Chinese medicine composition for treating sepsis. Crude drugs of the traditional Chinese medicine composition contain semen raphani, daemonorops draco, common burreed rhizome, cornu bubali, herba violae, honeysuckle, immature citron fruit, aleppo avens, common andrographis Herb, rheum officinale, multiflower knotweed vine, fragrant solomonseal rhizome, lophatherum gracile, scutellaria baicalensis, ginseng leaves, antelope horn, dark plum fruit, coriolus versicolor, hirudo, gecko, black bean, pubescent holly root, red-rooted salvia root, common macrocarpium fruit, radix rubiae, herba polygalae japonicae, herba rabdosiae, ladybell root and fructus alpiniae oxyphyllae. The traditional Chinese medicine composition has remarkable advantages of antibacterial action and antivirus effect, inflammation prevention, immunoregulation, low drug resistance rate and less side effect, and is capable of obviously improving clinical symptoms of patients, regulating coagulopathy, alleviating or inhibiting systemic inflammatory response, protecting system functions of various systems, reducing the incidence rate of complications, shortening the treatment time and improving the prognostic effect of the patients. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2622745-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017039487-A1 |
| priorityDate | 2013-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 300.